Advanced search
Publication Cover
Cancer Investigation Volume 12, 1994 - Issue 1
Submit an article Journal homepage
12
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Multiple Cycles of Dose-Intensive Cyclophosphamide, Etoposide, and Cisplatinum (DICEP) Produce Durable Responses in Refractory Non-Hodgkin's Lymphoma

James A. Neidhart University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
,
Ronald Kubica University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
,
Christine Stidley University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
,
Julia Pfile University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
,
Douglas Clark University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
&
John Rinehart University of New Mexico, Cancer Center and Department of Medicine Albuquerque, New Mexico, 87131
Pages 1-11 | Published online: 11 Jun 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Eva Kimby, Lars Brandt, Peter Nygren, Bengt Glimelius. (2001) A Systematic Overview of Chemotherapy Effects in Aggressive non-Hodgkin's Lymphoma. Acta Oncologica 40:2-3, pages 198-212.
Read now
Rashida Haq, Carol A. Sawka, Edmée Franssen & Neil L. Berinstein. (1999) Mitoxantrone-DHAP with GM-CSF: An Active but Myelosuppressive Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 35:5-6, pages 527-536.
Read now
Paul Goss, Frances Shepherd, J. Gerald Scott, Michael Baker, David Sutton & Simon Sutcliffe. (1995) Dice (Dexamethasone, Ifosfamide, Cisplatin, Etoposide) as Salvage Therapy in Non-Hodgkin's Lymphomas. Leukemia & Lymphoma 18:1-2, pages 123-129.
Read now

Articles from other publishers (7)

Douglas A. StewartNizar BahlisKaren ValentineAlex BaloghLynn SavoieDonald G. MorrisAllan JonesChris BrownJames A. Russell. (2006) Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma. Blood 107:12, pages 4623-4627.
Crossref
Alberto Ballestrero, Fabio Ferrando, Paola Stura, Maria Puglisi, Fulvio Brema & Franco Patrone. (1997) Standard-Dose Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) Allows Safe and Repeated Administration of High-Dose Cyclophosphamide, Etoposide, and Cisplatin (CEP). American Journal of Clinical Oncology 20:3, pages 266-271.
Crossref
Bertrand Coiffier. 1996. Advances in Lymphoma Research. Advances in Lymphoma Research 53 77 .
Jonathan C. Yau, James A. Neldhart, Pierre Triozzi, Shailendra Verma, John Nemunaitis, Donald P. Quick, David G. Mayernik, Dagmar H. Oette, Ann F. Hayes & John Holcenberg. (1996) Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. American Journal of Hematology 51:4, pages 289-295.
Crossref
. (1996) Hematopoietic Reconstitution with Autologous Stem Cells. New England Journal of Medicine 334:4, pages 271-272.
Crossref
James A. Neidhart, Don M. Morris & Terence S. Herman. (1994) Dose-intensification chemotherapy for patients with advanced breast cancer. Seminars in Radiation Oncology 4:4, pages 236-241.
Crossref
James A. Neidhart. (1993) Hematopoietic cytokines current use in cancer therapy. Cancer 72:S11, pages 3381-3386.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.